Related references
Note: Only part of the references are listed.Quantification of cardiac troponin I in human plasma by immunoaffinity enrichment and targeted mass spectrometry
Nicole A. Schneck et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2018)
Measurement of Lipoprotein-Associated Phospholipase A2 by Use of 3 Different Methods: Exploration of Discordance between ELISA and Activity Assays
Celalettin Topbas et al.
CLINICAL CHEMISTRY (2018)
Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods
Christophe Hirtz et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions
Andrew R. M. Bradbury et al.
MABS (2018)
Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range
Anna Sall et al.
PLOS ONE (2018)
Report on the 18th Annual Land O'Lakes Bioanalytical Conference
Erik C. Burns et al.
BIOANALYSIS (2018)
Surface plasmon resonance as a tool for ligand-binding assay reagent characterization in bioanalysis of biotherapeutics
Jia Duo et al.
BIOANALYSIS (2018)
Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure
Bernhard Halfinger et al.
CLINICAL CHEMISTRY (2017)
QUALITATIVE AND QUANTITATIVE CHARACTERIZATION OF PROTEIN BIOTHERAPEUTICS WITH LIQUID CHROMATOGRAPHY MASS SPECTROMETRY
Miao Qu et al.
MASS SPECTROMETRY REVIEWS (2017)
Biophysics: for HTS hit validation, chemical lead optimization, and beyond
Christine C. Genick et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3-LBA: immunogenicity, biomarkers and PK assays)
Shalini Gupta et al.
BIOANALYSIS (2017)
2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs)
Hendrik Neubert et al.
BIOANALYSIS (2017)
Characterization of labeled reagents in ligand-binding assays by a surface plasmon resonance biosensor
Jia Duo et al.
BIOANALYSIS (2017)
Orientation and characterization of immobilized antibodies for improved immunoassays
Nicholas G. Welch et al.
BIOINTERPHASES (2017)
Recommendations for Selection and Characterization of Protein Biomarker Assay Calibrator Material
Kyra J. Cowan et al.
AAPS JOURNAL (2017)
A candidate liquid chromatography mass spectrometry reference method for the quantification of the cardiac marker 1-32 B-type natriuretic peptide
Attila F. Torma et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Current Trends in Ligand Binding Real-Time Measurement Technologies
Stephanie Fraser et al.
AAPS JOURNAL (2017)
Generation and analyses of human synthetic antibody libraries and their application for protein microarrays
Anna Sall et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3-LBA, biomarkers and immunogenicity)
Susan Richards et al.
BIOANALYSIS (2016)
Hybridizing LBA with LC-MS/MS: the new norm for biologics quantification
Suma Ramagiri et al.
BIOANALYSIS (2016)
Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays
Robert J. Kubiak et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay
Yan G. Ni et al.
AAPS JOURNAL (2015)
Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow
Irene van den Broek et al.
METHODS (2015)
ANTIBODY ANARCHY: A CALL TO ORDER
Monya Baker
NATURE (2015)
Bioanalytical method validation considerations for LC-MS/MS assays of therapeutic proteins
Jeffrey X. Duggan et al.
BIOANALYSIS (2015)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3-LBA, biomarkers and immunogenicity)
Lakshmi Amaravadi et al.
BIOANALYSIS (2015)
Ligand Binding Assay Critical Reagents and Their Stability: Recommendations and Best Practices from the Global Bioanalysis Consortium Harmonization Team
Lindsay E. King et al.
AAPS JOURNAL (2014)
Catch and measure-mass spectrometry-based immunoassays in biomarker research
Frederik Weiss et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
False Biomarker Discovery due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125
Ioannis Prassas et al.
CLINICAL CHEMISTRY (2014)
Surface plasmon resonance immunoassay for the detection of the TNFα biomarker in human serum
Josu Martinez-Perdiguero et al.
TALANTA (2014)
Surface plasmon resonance: advances of label-free approaches in the analysis of biological samples
Tomas Riedel et al.
BIOANALYSIS (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3-LBA and immunogenicity)
Lauren Stevenson et al.
BIOANALYSIS (2014)
Conjugated critical reagent characterization for ligand-binding assays: using MALDI-TOF-MS as an orthogonal tool to assess assay performance
Jonathan Haulenbeek et al.
BIOANALYSIS (2014)
Characterization of critical reagents in ligand-binding assays: enabling robust bioanalytical methods and lifecycle management
Brian J. Geist et al.
BIOANALYSIS (2013)
Ligand Binding Assays in the 21st Century Laboratory: Recommendations for Characterization and Supply of Critical Reagents
Denise M. O'Hara et al.
AAPS JOURNAL (2012)
Identification of Low-Abundance Cancer Biomarker Candidate TIMP1 from Serum with Lectin Fractionation and Peptide Affinity Enrichment by Ultrahigh-Resolution Mass Spectrometry
Yeong Hee Ahn et al.
ANALYTICAL CHEMISTRY (2012)
Advances and challenges in analytical characterization of biotechnology products: Mass spectrometry-based approaches to study properties and behavior of protein therapeutics
Igor A. Kaltashov et al.
BIOTECHNOLOGY ADVANCES (2012)
Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma
Eric Kuhn et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars
Robert Nicholson et al.
BIOANALYSIS (2012)
Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS
Jessica Becker et al.
BIOANALYSIS (2012)
Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)
Mark Boterman et al.
BIOANALYSIS (2012)
MALDI Immunoscreening (MiSCREEN): A method for selection of anti-peptide monoclonal antibodies for use in immunoproteomics
Morteza Razavi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry
Jeffrey R. Whiteaker et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagents
Roland F. Staack et al.
BIOANALYSIS (2011)
Liquid Chromatography-Isotope Dilution-Mass Spectrometry as a New Basis for the Reference Measurement Procedure for Hemoglobin A1c Determination
Patricia Kaiser et al.
CLINICAL CHEMISTRY (2010)
Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry
Regine M. Schoenherr et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers
Jeffrey R. Whiteaker et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry
Eric Kuhn et al.
CLINICAL CHEMISTRY (2009)
SISCAPA Peptide Enrichment on Magnetic Beads Using an In-line Bead Trap Device
N. Leigh Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Toward Systeme International d'Unite-traceable protein quantification: From amino acids to proteins
William I. Burkitt et al.
ANALYTICAL BIOCHEMISTRY (2008)
Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet
Yasmina Abdiche et al.
ANALYTICAL BIOCHEMISTRY (2008)
Critical ligand binding reagent Preparation/Selection: When specificity depends on reagents
Bonita Rup et al.
AAPS JOURNAL (2007)
Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples
William Nowatzke et al.
AAPS JOURNAL (2007)
Specificity and selectivity evaluations of ligand binding assay of protein therapeutics against concomitant drugs and related endogenous proteins
Jean Lee et al.
AAPS JOURNAL (2007)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
L Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA)
NL Anderson et al.
JOURNAL OF PROTEOME RESEARCH (2004)
Serum heterophile antibodies interfere with prostate specific antigen test and result in over treatment in a patient with prostate cancer
BR Morgan et al.
JOURNAL OF UROLOGY (2001)
Share Paper
